|
1
|
Araghi M, Soerjomataram I, Jenkins M,
Brierley J, Morris E, Bray F and Arnold M: Global trends in
colorectal cancer mortality: Projections to the year 2035. Int J
Cancer. 144:2992–3000. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schreuders EH, Ruco A, Rabeneck L, Schoen
RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening:
A global overview of existing programmes. Gut. 64:1637–1649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li XX, Peng JJ, Liang L, Huang LY, Li DW,
Shi DB, Zheng HT and Cai SJ: RNA-seq identifies determinants of
oxaliplatin sensitivity in colorectal cancer cell lines. Int J Clin
Exp Pathol. 7:3763–3770. 2014.PubMed/NCBI
|
|
4
|
Cohen MS and Chang P: Insights into the
biogenesis, function, and regulation of ADP-ribosylation. Nat Chem
Biol. 14:236–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luscher B, Butepage M, Eckei L, Krieg S,
Verheugd P and Shilton BH: ADP-ribosylation, a multifaceted
posttranslational modification involved in the control of cell
physiology in health and disease. Chem Rev. 118:1092–1136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jain PG and Patel BD: Medicinal chemistry
approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as
anticancer agents-A recent update. Eur J Med Chem. 165:198–215.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kunze FA and Hottiger MO: Regulating
immunity via ADP-ribosylation: Therapeutic implications and beyond.
Trends Immunol. 40:159–173. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hendriks IA, Larsen SC and Nielsen ML: An
advanced strategy for comprehensive profiling of ADP-ribosylation
sites using mass spectrometry-based proteomics. Mol Cell
Proteomics. 18:1010–1026. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakthianandeswaren A, Parsons MJ, Mouradov
D, MacKinnon RN, Catimel B, Liu S, Palmieri M, Love C, Jorissen RN,
Li S, et al: MACROD2 haploinsufficiency impairs catalytic activity
of PARP1 and promotes chromosome instability and growth of
intestinal tumors. Cancer Discov. 8:988–1005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rajaram M, Zhang J, Wang T, Li J, Kuscu C,
Qi H, Kato M, Grubor V, Weil RJ, Helland A, et al: Two distinct
categories of focal deletions in cancer genomes. PLoS One.
8:e662642013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Wang J, Ding M and Yu Y:
Site-specific characterization of the Asp- and Glu-ADP-ribosylated
proteome. Nat Methods. 10:981–984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonfiglio JJ, Fontana P, Zhang Q, Colby T,
Gibbs-Seymour I, Atanassov I, Bartlett E, Zaja R, Ahel I and Matic
I: Serine ADP-ribosylation depends on HPF1. Mol Cell. 65:932–940
e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paone G, Wada A, Stevens LA, Matin A,
Hirayama T, Levine RL and Moss J: ADP ribosylation of human
neutrophil peptide-1 regulates its biological properties. Proc Natl
Acad Sci USA. 99:8231–8235. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ling F, Tang Y, Li M, Li QS, Li X, Yang L,
Zhao W, Jin CC, Zeng Z, Liu C, et al: Mono-ADP-ribosylation of
histone 3 at arginine-117 promotes proliferation through its
interaction with P300. Oncotarget. 8:72773–72787. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jing C, Ma R, Cao H, Wang Z, Liu S, Chen
D, Wu Y, Zhang J and Wu J: Long noncoding RNA and mRNA profiling in
cetuximab-resistant colorectal cancer cells by RNA sequencing
analysis. Cancer Med. 8:1641–1651. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vacchelli E, Ma Y, Baracco EE, Sistigu A,
Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, et
al: Chemotherapy-induced antitumor immunity requires formyl peptide
receptor 1. Science. 350:972–978. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin KT, Shann YJ, Chau GY, Hsu CN and
Huang CY: Identification of latent biomarkers in hepatocellular
carcinoma by ultra-deep whole-transcriptome sequencing. Oncogene.
33:4786–4794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kalathas D, Theocharis DA, Bounias D,
Kyriakopoulou D, Papageorgakopoulou N, Stavropoulos MS and Vynios
DH: Chondroitin synthases I, II, III and chondroitin sulfate
glucuronyltransferase expression in colorectal cancer. Mol Med Rep.
4:363–368. 2011.PubMed/NCBI
|
|
19
|
Kalathas D, Theocharis DA, Bounias D,
Kyriakopoulou D, Papageorgakopoulou N, Stavropoulos MS and Vynios
DH: Alterations of glycosaminoglycan disaccharide content and
composition in colorectal cancer: Structural and expressional
studies. Oncol Rep. 22:369–375. 2009.PubMed/NCBI
|
|
20
|
Jayson GC, Lyon M, Paraskeva C, Turnbull
JE, Deakin JA and Gallagher JT: Heparan sulfate undergoes specific
structural changes during the progression from human colon adenoma
to carcinoma in vitro. J Biol Chem. 273:51–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng L, Qian J, Luo X, Zhou A, Zhang Z and
Fang Q: CHSY1 promoted proliferation and suppressed apoptosis in
colorectal cancer through regulation of the NFκB and/or caspase-3/7
signaling pathway. Oncol Lett. 16:6140–6146. 2018.PubMed/NCBI
|
|
22
|
Hoshiba T: An extracellular matrix (ECM)
model at high malignant colorectal tumor increases chondroitin
sulfate chains to promote epithelial-mesenchymal transition and
chemoresistance acquisition. Exp Cell Res. 370:571–578. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bolger AM, Lohse M and Usadel B:
Trimmomatic: A flexible trimmer for Illumina sequence data.
Bioinformatics. 30:2114–2120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pertea M, Pertea GM, Antonescu CM, Chang
TC, Mendell JT and Salzberg SL: StringTie enables improved
reconstruction of a transcriptome from RNA-seq reads. Nat
Biotechnol. 33:290–295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okonechnikov K, Conesa A and
García-Alcalde F: Qualimap 2: Advanced multi-sample quality control
for high-throughput sequencing data. Bioinformatics. 32:292–294.
2016.PubMed/NCBI
|
|
27
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45(D1): D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mizumoto S, Yamada S and Sugahara K:
Molecular interactions between chondroitin-dermatan sulfate and
growth factors/receptors/matrix proteins. Curr Opin Struct Biol.
34:35–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoon YS, Kim JW, Kang KW, Kim YS, Choi KH
and Joe CO: Poly(ADP-ribosyl)ation of histone H1 correlates with
internucleosomal DNA fragmentation during apoptosis. J Biol Chem.
271:9129–9134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Voigt P, Tee WW and Reinberg D: A double
take on bivalent promoters. Genes Dev. 27:1318–1338. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gupte R, Liu Z and Kraus WL: PARPs and
ADP-ribosylation: Recent advances linking molecular functions to
biological outcomes. Genes Dev. 31:101–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hottiger MO: Nuclear ADP-ribosylation and
its role in chromatin plasticity, cell differentiation, and
epigenetics. Annu Rev Biochem. 84:227–263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu YM, Du JY and Lau AT: Posttranslational
modifications of human histone H3: An update. Proteomics.
14:2047–2060. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rakhimova A, Ura S, Hsu DW, Wang HY, Pears
CJ and Lakin ND: Site-specific ADP-ribosylation of histone H2B in
response to DNA double strand breaks. Sci Rep. 7:437502017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li M, Tang Y, Li Q, Xiao M, Yang Y and
Wang Y: Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1
to impair demethylation of tumor suppressor gene TFPI2. Oncogene.
38:3488–3503. 2019.
Castle JC, Loewer M, Boegel S, de Graaf J,
Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, et
al: Immunomic, genomic and transcriptomic characterization of
CT26 colorectal carcinoma. BMC Genomics 15: 190, 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Simonian M, Mosallaei M, Khosravi S and
Salehi R: rs12904 polymorphism in the 3′-untranslated region of
ephrin A1 ligand and the risk of sporadic colorectal cancer in the
Iranian population. J Cancer Res Ther. 15:15–19. 2019.PubMed/NCBI
|
|
37
|
Penney ME, Parfrey PS, Savas S and Yilmaz
YE: A genome-wide association study identifies single nucleotide
polymorphisms associated with time-to-metastasis in colorectal
cancer. BMC Cancer. 19:1332019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sveen A, Kilpinen S, Ruusulehto A, Lothe
RA and Skotheim RI: Aberrant RNA splicing in cancer; expression
changes and driver mutations of splicing factor genes. Oncogene.
35:2413–2427. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu J, Li H, Shen S, Sun L, Yuan Y and
Xing C: Alternative splicing events implicated in carcinogenesis
and prognosis of colorectal cancer. J Cancer. 9:1754–1764. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Resar L, Chia L and Xian L: Lessons from
the Crypt: HMGA1-Amping up Wnt for stem cells and tumor
progression. Cancer Res. 78:1890–1897. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee AJ, Endesfelder D, Rowan AJ, Walther
A, Birkbak NJ, Futreal PA, Downward J, Szallasi Z, Tomlinson IP,
Howell M, et al: Chromosomal instability confers intrinsic
multidrug resistance. Cancer Res. 71:1858–1870. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ahmed D, Eide PW, Eilertsen IA, Danielsen
SA, Eknæs M, Hektoen M, Lind GE and Lothe RA: Epigenetic and
genetic features of 24 colon cancer cell lines. Oncogenesis.
2:e712013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
van den Broek E, Dijkstra MJ, Krijgsman O,
Sie D, Haan JC, Traets JJ, van de Wiel MA, Nagtegaal ID, Punt CJ,
Carvalho B, et al: High prevalence and clinical relevance of genes
affected by chromosomal breaks in colorectal cancer. PLoS One.
10:e01381412015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Martinez-Zamudio R and Ha HC: Histone
ADP-ribosylation facilitates gene transcription by directly
remodeling nucleosomes. Mol Cell Biol. 32:2490–2502. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Abplanalp J and Hottiger MO: Cell fate
regulation by chromatin ADP-ribosylation. Semin Cell Dev Biol.
63:114–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Clouaire T and Legube G: A snapshot on the
Cis chromatin response to DNA double-strand breaks. Trends Genet.
35:330–345. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wintergerst L, Selmansberger M, Maihoefer
C, Schüttrumpf L, Walch A, Wilke C, Pitea A, Woischke C, Baumeister
P, Kirchner T, et al: A prognostic mRNA expression signature of
four 16q24.3 genes in radio(chemo)therapy-treated head and neck
squamous cell carcinoma (HNSCC). Mol Oncol. 12:2085–2101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhen Z: Effects of Histone H3
Arginine-specific Mono-ADP-ribosylation on proliferation and
apoptosis of human colon cancer cell and its possible mechanism.
Chongqing Med Univ; 2016
|
|
49
|
Mende M, Bednarek C, Wawryszyn M, Sauter
P, Biskup MB, Schepers U and Bräse S: Chemical synthesis of
glycosaminoglycans. Chem Rev. 116:8193–8255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liao WC, Yen HR, Liao CK, Tseng TJ, Lan CT
and Liu CH: DSE regulates the malignant characters of
hepatocellular carcinoma cells by modulating CCL5/CCR1 axis. Am J
Cancer Res. 9:347–362. 2019.PubMed/NCBI
|
|
51
|
Pudelko A, Wisowski G, Olczyk K and Kozma
EM: The dual role of the glycosaminoglycan chondroitin-6-sulfate in
the development, progression and metastasis of cancer. FEBS J.
286:1815–1837. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kopec M, Imiela A and Abramczyk H:
Monitoring glycosylation metabolism in brain and breast cancer by
Raman imaging. Sci Rep. 9:1662019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nikitovic D, Chatzinikolaou G, Tsiaoussis
J, Tsatsakis A, Karamanos NK and Tzanakakis GN: Insights into
targeting colon cancer cell fate at the level of
proteoglycans/glycosaminoglycans. Curr Med Chem. 19:4247–4258.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Qi J, Yu Y, Akilli Öztürk Ö, Holland JD,
Besser D, Fritzmann J, Wulf-Goldenberg A, Eckert K, Fichtner I and
Birchmeier W: New Wnt/β-catenin target genes promote experimental
metastasis and migration of colorectal cancer cells through
different signals. Gut. 65:1690–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ji CH and Kwon YT: Crosstalk and interplay
between the ubiquitin-proteasome system and autophagy. Mol Cells.
40:441–449. 2017.PubMed/NCBI
|
|
56
|
Zhou W and Slingerland JM: Links between
oestrogen receptor activation and proteolysis: Relevance to
hormone-regulated cancer therapy. Nat Rev Cancer. 14:26–38. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhi J, Sun J, Wang Z and Ding W: Support
vector machine classifier for prediction of the metastasis of
colorectal cancer. Int J Mol Med. 41:1419–1426. 2018.PubMed/NCBI
|
